InvestorsHub Logo
Followers 22
Posts 587
Boards Moderated 0
Alias Born 08/19/2020

Re: aGuyUS post# 26707

Thursday, 10/15/2020 3:40:49 PM

Thursday, October 15, 2020 3:40:49 PM

Post# of 44690
I think you might be "seeing" it wrong...

The title is...
Relief Therapeutics (OTC:RLFTF): NeuroRx to list on NYSE via Merger

Which to me looks like this is an update about RLFTF stock for RLFTF investors, and that update is... their partner (Neuro) is seeking to list on NYSE via a merger approach.

That's why there is a colon (:) after Relief Therapeutics.

And then... in the article, it states...

"NeuroRx a company who is partnered with promising COVID-19 therapeutic maker Relief Therapeutics (OTC: RLFTF) has decided to merge and list with a NYSE company (3-6 months)."

So... the way the sentence is structured, someone could misunderstand that the merge is between Relief and Neuro, but in fact, the rest of the sentence says "merge and list with a NYSE company".

So... look at the article as an update for RLFTF investors... that's what I think it was intended to do.

But yeah... although the title is technically done right, it inadvertently comes across a bit misleading.

Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.